Sponsor:
Emory University
Code:
NCT07859722
Conditions
Prostate Carcinoma
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Magnetic Resonance Imaging
Questionnaire Administration
Brief summary:
Conditions
Prostate Carcinoma
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage III Prostate Cancer AJCC v8
Study ID
NCT07859722
Start date
Oct 22, 2026
Status verified date
Oct, 2026
Completion date
May 31, 2029
Anticipated
Primary completion date
May 31, 2028
Anticipated
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
100 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Arm A (CT, SOC HDR brachytherapy)
experimental: Arm B (CT, MRI, SOC HDR brachytherapy)
Interventions
Magnetic Resonance Imaging
Questionnaire Administration
Primary outcome measure
Central contacts
Locations
Emory Proton Therapy Center
Recruiting
Atlanta, Georgia, United States, 30308
Contacts
Emory University Hospital Midtown
Recruiting
Atlanta, Georgia, United States, 30308
Contacts
Principal Investigator:
Kamran Salari, MD
Emory University Hospital/Winship Cancer Institute
Recruiting
Atlanta, Georgia, United States, 30322
Contacts
Principal Investigator:
Kamran Salari, MD
Sponsor
Emory University
Last update posted
Nov 2, 2026
Last verified
Oct, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-03. This information was provided to ClinicalTrials.gov by Emory University on 2026-11-02. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.